Search results
Goldman Sachs downgrades Roche stock, cites pessimistic margin forecasts By Investing.com
Investing.com· 3 days agoOn Thursday, Goldman Sachs (NYSE:GS) initiated coverage on Roche Holding AG (OTC:RHHVF) (ROG:SW)...
Swiss biotech ecosystem recuperates from global financial instability
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe SGE is unconcerned by actions from companies such as listing on external stock exchanges, seeing...
Exploring Swiss Dividend Stocks In May 2024
Simply Wall St. via Yahoo Finance· 4 days agoAmidst a cautious atmosphere driven by inflation concerns and interest rate outlooks, the Swiss market experienced a downturn, with the benchmark SMI...
Three Leading Swiss Dividend Stocks With Yields Up To 6.1%
Simply Wall St. via Yahoo Finance· 3 days agoSwiss stocks experienced a downturn on Tuesday, influenced by global economic concerns including...
Swiss Market Ends Weak Again
RTT News· 4 days agoSwiss stocks turned in a weak performance on Tuesday as concerns about the outlook for Federal Reserve's interest rates weighed on sentiment. Data on U.S. personal income ...
Health Care Roundup: Market Talk
The Wall Street Journal· 4 days agoSwiss-traded shares closed at CHF228.80 on Tuesday. (david.sachs@wsj.com) 2217 ET – Supermax Corp... raises Supermax’s target price to MYR0.96 from...
Goldman Sachs Says Buy European Pharma Stocks Touting Innovation
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- European drugmakers that are focused on building portfolios of new medicines have...
Immunovant changes up plans for closely watched autoimmune drugs
BioPharma Dive via Yahoo Finance· 3 days agoThe company is prioritizing development of an earlier so-called FcRn inhibitor, a type of medicine...
